GEVO (GEVO) beneficial owner plans sale of 10,257 common shares

Rhea-AI Filing Summary

GEVO, Inc. has a beneficial owner, Kimberly Bowron, planning to sell common stock under a securities notice. The planned sale includes 10,257 shares of common stock, with an indicated aggregate market value of $15,855.27, to be sold through Stifel Nicolaus & Company Inc. on or after August 6, 2026 on Nasdaq.

The shares derive from 38,515 restricted stock awards originally issued on August 3, 2023 as equity compensation. The filing also reports that Bowron sold 25,101 shares for $44,173.00 on May 27, 2026 and 15,470 shares for $22,048.00 on June 12, 2026 in prior transactions.

Key Figures

Shares planned for sale: 10,257 shares Aggregate market value of planned sale: $15,855.27 Restricted stock awards: 38,515 shares +3 more

6 metrics

Shares planned for sale 10,257 shares Common stock to be sold through Stifel Nicolaus & Company Inc. on or after August 6, 2026

Aggregate market value of planned sale $15,855.27 Value associated with the 10,257 shares of common stock planned for sale

Restricted stock awards 38,515 shares Restricted stock awards granted on August 3, 2023 as equity compensation

Shares outstanding 243,411,329 shares Outstanding GEVO common stock referenced in the sale disclosure

Prior sale on May 27, 2026 25,101 shares for $44,173.00 Common stock sold by Kimberly Bowron during the past three months

Prior sale on June 12, 2026 15,470 shares for $22,048.00 Second reported sale by Kimberly Bowron during the past three months

Key Terms

Form 144, Restricted Stock Awards, Equity Compensation

3 terms

Form 144 regulatory

"144: Securities Information Common Stock | Stifel Nicolaus & Company Inc"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Awards financial

"Common Stock | 08/03/2023 | Restricted Stock Awards | Issuer"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Equity Compensation financial

"08/03/2023 | Restricted Stock Awards | Issuer | | | 38515 | 08/06/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:08 PM Accepted by SEC EDGAR 08/06/2026 - 04:07 PM Learn about SEC filing dates

FAQ

What stock sale is being reported for GEVO (GEVO)?

A beneficial owner, Kimberly Bowron, plans to sell 10,257 shares of GEVO common stock through Stifel Nicolaus & Company Inc., with an aggregate market value of $15,855.27, on or after August 6, 2026 on Nasdaq.

What is the source of the GEVO (GEVO) shares being sold?

The shares planned for sale come from restricted stock awards. The filing notes 38,515 restricted stock awards granted on August 3, 2023 as equity compensation, which are the underlying securities for the planned sale.

Which broker is handling the planned GEVO (GEVO) stock sale?

The planned sale of GEVO common stock is to be executed through Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102, with the shares to be sold on the Nasdaq market.

What GEVO (GEVO) stock has Kimberly Bowron sold in the past three months?

The filing reports two prior sales: 25,101 shares of GEVO common stock for $44,173.00 on May 27, 2026, and 15,470 shares for $22,048.00 on June 12, 2026.

How many GEVO (GEVO) shares are reported outstanding in this notice?

The notice lists 243,411,329 shares of GEVO common stock as outstanding in connection with the planned sale disclosure. This figure provides overall capital structure context and is separate from the specific shares planned for sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	10257	15855.27	243411329	08/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/03/2023	Restricted Stock Awards	Issuer			38515	08/06/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kimberly Bowron 345 INVERNESS DRIVE SOUTH BUILDING C SUITE 310 ENGLEWOOD CO 80112	Common Stock	05/27/2026	25101	44173.00
Kimberly Bowron 345 INVERNESS DRIVE SOUTH BUILDING C ENGLEWOOD CO 80112	Common Stock	06/12/2026	15470	22048.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)